Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department

Key points

• Transient ischemic attack (TIA) is defined by tissue, not time: focal neurological symptoms in a vascular territory that resolve rapidly and completely, with no infarct on diffusion-weighted imaging (DWI) MRI.
• The estimated 90-day stroke risk after TIA ranges from 10% to 18%.
• Vessel imaging should be a routine part of acute imaging; MRI is the preferred modality to rule out acute infarction.
• Patients benefit from early neurology consultation in the ED (in person or by teleneurology) or follow-up within 1 week, ideally within 48 hours.
• For high-risk TIA (ABCD2 score of 4 or more), aspirin 81 mg plus clopidogrel 75 mg daily for 21-90 days, then single antiplatelet therapy.

Overview

This American Heart Association (AHA) scientific statement covers the clinical diagnosis, risk assessment, disposition and risk reduction of patients with suspected TIA in the emergency department (ED). TIA is a strong predictor of ischemic stroke, and each center should use its available resources to build a pathway for rapid evaluation and secondary prevention.

Diagnosis and mimics

Older age, vascular risk factors, abrupt onset with maximal symptoms at onset, duration typically under 60 minutes, preserved mentation and focal symptoms matching a vascular territory favor TIA. Younger age without risk factors, a history of epilepsy, migraine or brain tumor, spreading symptoms, altered mentation and positive visual phenomena suggest a mimic. With diagnostic uncertainty, a neurovascular workup is suggested.

Workup

Non-contrast CT helps exclude hemorrhage, masses and subacute stroke but is insensitive for small infarcts; MRI usually follows, and CT can be avoided in a stable patient with resolved symptoms if rapid MRI is available. CT angiography of head and neck is considered safe in chronic kidney disease. Laboratory tests include glucose, complete blood count, chemistry panel, hemoglobin A1c and lipids, with erythrocyte sedimentation rate and C-reactive protein for temporal arteritis in patients over 50. Telemetry, troponin and electrocardiography screen for atrial fibrillation; transthoracic echocardiography may be arranged as an expedited outpatient study within one week when suspicion of a cardioembolic source is low.

Risk stratification and disposition

ABCD2, ABCD3 and ABCD3-I scores guide disposition together with a full evaluation. With a high ABCD2 score (6-7), stroke risk is 8.1% at 2 days, 11.7% at 7 days and 17.8% at 90 days, versus 1.0%, 1.2% and 3.1% with a low score (0-3). High risk scores or imaging features, severe hypertension, dual TIA, severe metabolic derangements or abnormal ECG findings such as new atrial fibrillation may warrant admission. Expedited TIA pathways reduce delays, length of stay, admissions and costs without increasing short-term stroke risk or mortality.

Secondary prevention

Antiplatelet therapy should start within 12-24 hours of symptom onset in patients without an indication for anticoagulation; anticoagulation for atrial fibrillation can be prescribed from the ED. Long-term goals are blood pressure below 130/80 mm Hg and LDL cholesterol below 70 mg/dl, with statins first line, plus a low-sodium or Mediterranean diet, smoking cessation, physical activity and alcohol moderation.

Frequently asked questions

Is a 24-hour time limit still part of the TIA definition?

No. Time-based characteristics are no longer used; resolved symptoms with an infarct on DWI MRI indicate ischemic stroke.

How soon should patients be seen after a TIA?

Neurology consultation in the ED or clinic follow-up ideally within 48 hours and no later than 1 week.

Who should be admitted?

Patients with high risk scores or imaging features and other high-risk findings, and patients in underserved areas with barriers to timely care.

Source

Amin HP, Madsen TE, Bravata DM, Wira CR, Johnston SC, Ashcraft S, et al.; on behalf of the American Heart Association Emergency Neurovascular Care Committee of the Stroke Council and Council on Peripheral Vascular Disease. Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department Setting: A Scientific Statement From the American Heart Association. Stroke 2023. doi:10.1161/STR.0000000000000418. This summary was prepared by Medpresso from the original publication and the AHA professional summary and is not a substitute for the full text or medical advice.